Sponsor

Centre Jean Perrin

Clinical research sponsor

Published trials35
Recruiting shown3
Roles2
SourceClinicalTrials.gov

Clinical trials

35 shown
Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer SurgeryNCT06512558 · lead sponsor · 2024-11-14
RECRUITING
Intrinsic Validity of Molecular Marker(s) Detection on Tissular Tumoral DNA to Predict the Efficacy of 177Lutetium-PSMA-617 (Lu-PSMA) Treatment for Castration-resistant Metastatic Prostate CancerNCT06600802 · lead sponsor · 2024-10-08
RECRUITING
Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast CancerNCT04133077 · lead sponsor · 2021-11-19
RECRUITING
Functional Imaging of Digital Osteoarthritis and Rheumatoid Arthritis Using 99mTc-NTP 15-5 in Nuclear MedicineNCT07624994 · lead sponsor · 2026-08-01
NOT_YET_RECRUITING
Support and Post-therapeutic Rehabilitation for Women in Complete Remission of Breast Cancer in a Thermal EnvironmentNCT05433077 · lead sponsor · 2022-06-27
ACTIVE_NOT_RECRUITING
Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer ScreeningNCT04273542 · lead sponsor · 2021-05-31
ACTIVE_NOT_RECRUITING
Breast Localization: RFID Tags vs Wire LocalizationNCT04750889 · lead sponsor · 2021-05-15
COMPLETED
Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer PatientsNCT04438681 · lead sponsor · 2020-11-27
ACTIVE_NOT_RECRUITING
Assessment of 99mTc-NTP 15-5 Uptake on Cartilage, a New Proteoglycan TracerNCT04481230 · lead sponsor · 2020-11-12
COMPLETED
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer PatientsNCT04068623 · lead sponsor · 2019-12-04
ACTIVE_NOT_RECRUITING
Loreline Study: Characterization of Long Responders Under EribulineNCT03771183 · lead sponsor · 2019-08-23
COMPLETED
Satisfaction Assessment of Patients With Local Breast Cancer When Using Cosmetics During Chemotherapy and Post-treatment Thermal CureNCT03684135 · lead sponsor · 2018-08-03
COMPLETED
Adapted Physical Activity for Breast Cancer HER2 Positive PatientNCT02963363 · lead sponsor · 2018-04-27
TERMINATED
Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer PatientsNCT03197805 · lead sponsor · 2017-10-16
TERMINATED
Microbiota and the Lung CancerNCT03068663 · lead sponsor · 2017-05-23
ACTIVE_NOT_RECRUITING
Effects of Preoperative Rehabilitation in Patients Resected for Lung CancerNCT03020251 · lead sponsor · 2017-05-12
COMPLETED
Impact of a Psychoeducational Intervention on Expectations and Coping in Young Women Exposed to a High HBOC RiskNCT02705924 · lead sponsor · 2016-04-01
TERMINATED
Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)NCT02509871 · lead sponsor · 2015-07-01
COMPLETED
Adaptated Physical Activity in CancerologyNCT02252991 · lead sponsor · 2014-09-01
TERMINATED
Impact of Chemo-induced Menopause on Quality of Life in Women <45 Years Old, Diagnosed With Non-metastatic Breast CancerNCT02102568 · lead sponsor · 2014-04-01
COMPLETED
Multicenter Study Comparing Taxotere Plus Curcumin Versus Taxotere Plus Placebo Combination in First-line Treatment of Prostate Cancer Metastatic Castration Resistant (CURTAXEL)NCT02095717 · lead sponsor · 2014-03-01
TERMINATED
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and TaxanesNCT01910870 · lead sponsor · 2013-07-01
TERMINATED
Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and TaxanesNCT01910844 · lead sponsor · 2013-07-01
TERMINATED
Contribution of MRI in the Evaluation of Apparent Diffusion Coefficient and Prediction of Response to Neoadjuvant Chemotherapy in Breast CancerNCT01956513 · lead sponsor · 2012-03-01
WITHDRAWN
Etude Tomos- Apport de la Tomosynthèse Dans le Bilan d'Extension locorégional préthérapeutique d'Une Tumeur du Sein : Recherche de multicentricité Tomos Study- Contribution of Tomosynthesis In Locoregional Pretherapeutic Staging of a Breast Tumor: Multicentricity SearchNCT01522300 · lead sponsor · 2012-01-01
TERMINATED
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- LapatinibNCT01847599 · lead sponsor · 2011-09-06
TERMINATED
Weight Variation During Chemotherapy in Breast Cancer PatientsNCT01506466 · lead sponsor · 2011-09-01
COMPLETED
Assessment of the Efficacy of the Neoadjuvant Combination: "Chemotherapy-Targeted Therapy" in Breast Cancer.NCT00933517 · lead sponsor · 2009-09-01
COMPLETED
Docetaxel With a Phytochemical in Treating Patients With Hormone Independent Metastatic Prostate CancerNCT01012141 · lead sponsor · 2009-09-01
COMPLETED
Docetaxel With or Without a Phytochemical in Treating Patients With Breast CancerNCT00852332 · lead sponsor · 2009-08-01
TERMINATED
Support and Rehabilitation Protocol for Non Metastatic Breast Cancer Patients in Complete Remission After ChemotherapyNCT01563588 · lead sponsor · 2008-12-01
TERMINATED
Assessment of the Efficacy of a Neoadjuvant Combination: "Chemotherapy-targeted Therapy" in Breast Cancer.NCT00600249 · lead sponsor · 2008-01-01
COMPLETED
Breast Cancer Treated by Neoadjuvant ChemotherapyNCT00425516 · lead sponsor · 2007-01-01
COMPLETED
Studying Biopsy Samples in Women Undergoing First-Line Chemotherapy for Metastatic Breast CancerNCT00870168 · lead sponsor · 2006-01-01
COMPLETED
CEPPPIA Pilot. Experimental Center of Participative and Individualized Predictive Prevention in AuvergneNCT03378895 · collaborator · 2017-12-01
COMPLETED

Sponsor roles

lead sponsor34
collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.